Novozymes A/S 最大收入來源為 Bioenergy,在最近的收益報告中收入為 596,326,170。就地區而言,Europe, Middle East & Africa 是 Novozymes A/S 的主要市場,收入為 1,440,200,000。
Novozymes A/S 是否盈利?
是的,根據最新的財務報表,Novozymes A/S 的淨利潤為 $583
Novozymes A/S 有負債嗎?
是的,Novozymes A/S 的負債為 5,493
Novozymes A/S 的流通股有多少?
Novozymes A/S 的總流通股為 465.91
關鍵數據
前收市價
$54.3
開盤價
$56.25
當日範圍
$55.58 - $56.47
52週區間
$53.95 - $75.99
交易量
22.6K
平均成交量
54.1K
股息收益率
--
每股盈餘 (TTM)
1.39
市值
$23.1B
什麼是 NOVONESIS A S?
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..